#TNFIs - Twitter Hashtag

over 2 years ago

#ACR23 late breaking: Korean population based study- #TNFis exposure (vs. #bDMARDs non-exposure) was associated with 30% lower risk of #cardiovascular events in patients with AS. #IL-17i exposure had no impact. https://t.co/WazUwOqdYA

LatikaGupta_'s tweet photo. #ACR23 late breaking: Korean population based study- #TNFis exposure (vs. #bDMARDs non-exposure) was associated with 30% lower risk of #cardiovascular events in patients with AS. #IL-17i exposure had no impact. https://t.co/WazUwOqdYA https://t.co/D0JSnN1W9w

1

11

8

1

4K

Seb

@ibdseb

almost 3 years ago · Vienna

Thank you @Alboraie & @DCharabaty for the invite for this excellent programme #ESCCO2023 @ESCCO_Society Looking forward to discussing how the old 🐕 (#TNFis) still around to bark …

Dr. Mohamed Alboraie MD. FRCP

@Alboraie

almost 3 years ago

Join us for a 🌎 class #IBD meeting with an amazing faculty in #ESCCO2023 @ESCCO_Society #GIFriends joining in from different time zones ⏰ #MedEdWithoutBorders @ibdseb @ibdgijami @DrJessicaA @SchwartzbergMD @DrJordanAxelrad @DhereMdEmory @drsusankais @KristleLynchMD @LindaNguyenMD @IBDBen @IBD_Houston @AtoosaRabiee @Bealoquebea @P_DeepakIBDMD @LindaNguyenMD @GKochharMD @JHashashMD @SchairerIBDMD @ibdgijami @NabilQuraishi @RajaAtreya @ReezwanaCMD @IBD_FloMD @SaraElOualiMD @DhereMdEmory @VicentHernande9 @waqqasafif @EugeneYenMD @AdamFeyen @golob Live streaming is available here 👇🏻: https://t.co/hZb4NMlVx5 Full program is available here 👇🏻: https://t.co/XifTPOQTl4

Alboraie's tweet photo. Join us for a 🌎 class #IBD meeting with an amazing faculty in #ESCCO2023 @ESCCO_Society

#GIFriends joining in from different time zones ⏰ #MedEdWithoutBorders
@ibdseb
@ibdgijami @DrJessicaA @SchwartzbergMD @DrJordanAxelrad @DhereMdEmory @drsusankais @KristleLynchMD @LindaNguyenMD @IBDBen @IBD_Houston @AtoosaRabiee @Bealoquebea @P_DeepakIBDMD @LindaNguyenMD @GKochharMD @JHashashMD @SchairerIBDMD @ibdgijami
@NabilQuraishi @RajaAtreya @ReezwanaCMD @IBD_FloMD
@SaraElOualiMD @DhereMdEmory @VicentHernande9 @waqqasafif @EugeneYenMD @AdamFeyen @golob

Live streaming is available here 👇🏻:
https://t.co/hZb4NMlVx5

Full program is available here 👇🏻:

https://t.co/XifTPOQTl4

0

26

5

1

5K

1

8

1

802

Janet Pope @Janetbirdope

about 4 years ago

MACE events no diff in German RA Rabbit registry of only humans shows #baricitinib and #tofacitinib vs #TNFis @RheumNow @eular_org #EULAR2022 OP0135

Aurelie Najm

@AurelieRheumo

about 4 years ago

RABBIT registry and MACE in RA No difference between *JAKi (Tofa and Bari) and *TNFi in both unselected and high CV risks patients. �� different than ORAL surveillance but Observational and overall Low incidence (28 events). #EULAR2022 @RheumNow OP0135

AurelieRheumo's tweet photo. RABBIT registry and MACE in RA
No difference between
*JAKi (Tofa and Bari) and *TNFi in both unselected and high CV risks patients.
�� different than ORAL surveillance
but Observational and overall Low incidence (28 events).

#EULAR2022 @RheumNow OP0135 https://t.co/o8rngHrwQF

0

5

3

0

4

2

0

Rheumatology & Rheumatology Advances in Practice @RheumJnl

over 4 years ago

NEW: @michaelnissen et al. ask: does a csDMARD in combination with a TNF inhibitor have an influence on drug retention and clinical remission in axial SpA? Read the latest findings in 24,000 patients from the #EuroSpA cohort 👇 https://t.co/zQ3EnmsbeG #axSpA #TNFis

0

3

1

0

Seb

@ibdseb

over 4 years ago

#ECCO2022 P Lakatos 👇Good review in @Gut_BMJ of #EIM in #IBD from @IBDMD @PeyrinBiroulet @IBD_FloMD and others 👑 - #TNFis https://t.co/R9QYLNQqAu

0

6

4

1

0

Seb

@ibdseb

over 4 years ago

#ECCO2022 @NarulaNeeraj Polled analysis - open access platform (👏👏 ) 4 clinical trials Which is the best drug for Ileal and Colonic disease Some limitations Old 🐶 - #TNFis perform still better

ibdseb's tweet photo. #ECCO2022
@NarulaNeeraj
Polled analysis - open access platform (👏👏 ) 4 clinical trials
Which is the best drug for
Ileal and Colonic disease
Some limitations
Old 🐶 - #TNFis perform still better https://t.co/uPHZb5asuO

0

6

0

Dermatology Advisor @DermAdvisor

about 6 years ago

Treatment with #TNFis vs #methotrexate alone is not associated with a decreased risk for progression to #psoriaticarthritis in patients with #psoriasis. #DermTwitter https://t.co/CaNgOALS45

0

2

0

Resistomap @resistomap

over 7 years ago

Resistomap Oy is honored as one of the 10 Startups to pitch at the 5th annual #InnoFrugal conference (https://t.co/VmSD1THnik), Helsinki, May 7-8, 2019. #frugalinnovation #impactinvesting #SDG #TNFIS